Significance of the imidazoline receptors in toxicology.
Kansas City, United States. In Clin Toxicol (phila), Jun 2014
Imidazoline-2 (I-2) receptors interact with monoamine oxidase A and monoamine oxidase B leading to research that has focused on the effect of I-2 receptors and depression and the suggestion of a possible antidepressant action of the imidazolines.
[Drug treatment of early-stage (de novo and "honeymoon") Parkinson disease].
Créteil, France. In Rev Neurol (paris), Apr 2014
Like monoamine oxidase inhibitors B (MAOI-B), synthetic dopamine agonists exhibit several advantages: easy-to-use treatment with a once-daily administration, delayed L-Dopa initiation, significant efficacy on motor symptoms (although lower than that of L-Dopa).